February 4, 2021
Mobilizing Transportation to Support
COVID-19 Vaccination Efforts

Your moderator fortoday

NCMM is a technical assistance center
funded by the Federal Transit
Administration

Amy Conrick
Director, National Center for Mobility
Management

We work daily to promote customercentered mobility strategies to advance
good health, economic vitality, selfsufficiency, and community.

As you prepare to join us . . . a few reminders§ This webinar is being recorded. The recording, slides, anda transcript will be posted at nc4mm.org/covid-19resource-center/§ All participants are joining in listen-only mode.
§ Please use the Q&A box to post any questions you have.
§ You may enable the captioning feature for this webinar byclicking on the option at the bottom of your screen.

3

Our Agenda
Setting the Context:§ Centers for Disease Control and Prevention§ National Assn. of City and County Health Officials§ Community Transportation Assn. of America

Panel Discussion:§ U. Mass Medical School – Baystate/Springfield, MA
Vaccination Task Force§ Texas Department of Transportation§ Spartan Transportation (TX)
§ Office of Emergency Medical Services, NHTSA§ Allegan County, MI
Audience Questions
4FTA and related resources: Incidental Use
1) FTA’s fact sheet on incidental use:
https://www.transit.dot.gov/ccam/about/dot-fta-hud-pih-partnershipcovid-19-recovery-fact-sheet2) Related FAQs, such as FAQs CE18, CE10 and CE4:https://www.transit.dot.gov/frequently-asked-questions-fta-granteesregarding-coronavirus-disease-2019-covid-19
3) Table of transit “incidental” use during the COVID-19 pandemic:
nc4mm.org/ccam4) Inventory of federal programs that support human service transportation:
https://www.transit.dot.gov/regulations-andguidance/ccam/about/ccam-program-inventory]5

Table of transit activities related to vaccination efforts
https://nc4mm.org/covid-19-resource-center/Share your examples of“incidental use” and transportation
support of vaccination efforts byemailing
info@nc4mm.org

Our Presenters

Dr. Janell Routh

Dr. Oscar Alleyne

Scott Bogren

Co-Deputy of theImplementation Planning Unitof the Vaccine Task Force

Chief of Programs &Services

Executive Director

Centers for Disease
Control and Prevention
8

COVID-19 Vaccine
Implementation
Dr. Janell Routh
February 4, 2021
For more information: www.cdc.gov/COVID19

COVID-19 Vaccine Distribution and Initiation
As of February 1, 2021

Available: https://covid.cdc.gov/covid-data-tracker

2/1/21COVID-19 Vaccines Under FDA Emergency Use Authorizations (EUAs)§ Two vaccines have received Emergency Use Authorizations (EUAs) from theFDA:– Pfizer/BioNTech: 2 doses given at least 21 days apart– Moderna: 2 doses given at least 28 days apart§ Both vaccines were tested in tens of thousands of adults from diverse
backgrounds, including older adults and communities of color.
§ Clinical trial data show that both vaccines are safe and effective atpreventing COVID-19.
§ It is unknown how long protection from vaccines might last.
Sources: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-conclude-phase-3-study-covid-19-vaccine
https://investors.modernatx.com/news-releases/news-release-details/modernas-covid-19-vaccine-candidate-meets-its-primary-efficacy
2/2/21Distribution and Administration
Later in distribution: vaccines will be administered tobroader populations through many different administrationsites, with focus on ensuring equity and expanding accessPharmacies

In early-phase distribution: COVID-19 vaccines will beadministered in focused areas for priority groups

Doctor's Offices
LTC Providers
Home BoundHealthcare Personnel

Mobile Units
Long-Term Care Facility Residents
Public Health Clinics / FQHCs
Public Health Clinics

Indian Health Service
Other federal entity sites (DOD)
Hospitals
Mass Vx – large outpatient clinics
2/2/21

Overview of Groups Prioritized by ACIP
Phase 1aPhase 1bPhase 1cPhase 2

ü Healthcarepersonnel

ü Frontline essentialworkers

ü Persons aged 6574 years

ü Long-term carefacility residentsü Persons aged 75years and older

ü Persons aged 1664 years with highrisk conditions

ü All people aged 16years and older not
in Phase 1 who arerecommended forvaccination

ü Essential workers
not recommendedin Phase 1b
Initiation of phases will be overlapping
Phase 1aPhase 1bPhase 1cPhase 2
2/2/21ACIP: COVID-19 Vaccine Guiding Principles

EQUI
TY

Efficient Distribution. During a pandemic, efficient, expeditious,and equitable distribution and administration of authorized vaccine
is critical

Flexibility. Within national guidelines, state and local jurisdictions

should have flexibility to administer vaccine based on local
epidemiology and demand

2/2/21

Additional considerations for rural communities§ Older, lower income, more underlying health conditions than urban§ Rural healthcare infrastructure issues§ Limited access to broadband and digital technology§ Limited transportation resources

2/2/21COVID-19 and Vaccine Basics

Key Facts about COVID-19 Vaccination

Getting vaccinatedcan help prevent you
from getting sickwith COVID-19

People who havealready gotten sickwith COVID-19 maystill benefit fromgetting vaccinated

COVID-19 vaccines
cannot give you
COVID-19

COVID-19 vaccines
will not cause you totest positive on
COVID-19 viral tests*

https://www.cdc.gov/coronavirus/2019-ncov/vaccines/about-vaccines/vaccine-myths.html*https://www.cdc.gov/coronavirus/2019-ncov/hcp/testing-overview.html

2/2/21COVID-19 and Vaccine Basics

Safety of COVID-19 Vaccines is a Top Priority
COVID-19 vaccines are being held to the same safety standards as all vaccines.
Before Authorization

After Authorization

ACIP§

FDA carefully reviews all safety data fromclinical trials.

§ACIP reviews all safety data before
recommending use.

§FDA and CDC closely monitor vaccine
safety and side effects. There are systems
in place that allow CDC and FDA to watch
for safety issues.

V-safe: https://www.cdc.gov/coronavirus/2019ncov/vaccines/safety/vsafe.html
2/2/21

Active Safety Monitoring for COVID-19Vaccines§ V-safe is a new CDC smart-phone based monitoring
program for COVID-19 vaccine safety:§ Uses text messaging and web surveys to check in withvaccine recipients after vaccination.
§ Participants can report any side effects or health problems
after COVID-19 vaccination.
§ Includes active telephone follow-up by CDC for reports ofsignificant health impact.

2/2/21COVID-19 and Vaccine Basics

Vaccination is one measure to help
stop the pandemic§

While COVID-19 vaccines appear to be highly effective,
additional preventive tools remain important to limit
the spread of COVID-19.

§The combination of getting vaccinated and following
CDC recommendations to protect yourself and others
offers the best protection from COVID-19.
–

Cover your nose and mouth with a mask.

–

Stay at least 6 feet from people who don’t live with you.

–

Avoid crowds and poorly ventilated indoor spaces.

–

Wash your hands.

2/2/21CDC Resources
Learn more with CDC’s COVID-19 vaccine tools andresources. Find information for COVID-19 vaccine
administration, storage, reporting, patient education,and more.
• COVID-19 Vaccination:
https://www.cdc.gov/vaccines/covid-19/index.html• For Healthcare Professionals:
https://www.cdc.gov/vaccines/covid19/hcp/index.html

COVID-19 Vaccine Communication Toolkits-Medical Centers, Clinics, and CliniciansLong-Term Care Facilities
Community-Based Organizations
Essential Workers

2/2/21

Thank youPublic Health and Transportation:
Working Together toMove Communities Past COVID-19
E. Oscar Alleyne, DrPH MPH
Senior Advisor, Public Health Programs

Who is NACCHO?

NACCHO is comprised of nearly

3,000 local healthdepartments across the United States. Our mission is to serve
as a leader, partner, catalyst, and voice withlocal health departments.

The Local Public Health Landscape

Source: National Association of County and City Health Officials (NACCHO) 2019 National Profile of Local Health Departments

Local Health Departments ProvideImmunization Services

Source: National Association of County and City Health Officials (NACCHO) 2019 National Profile of Local Health Departments

Local Health Department Partnerships

Source: National Association of County and City Health Officials (NACCHO) 2019 National Profile of Local Health Departments

Strengthening Public Health Systems and Services through Building
Capacity for Local Health Department Immunization Programs toAddress Vaccine Preventable Diseases

NACCHO Immunization Program Activities
1. Enhance LHD contributions that inform policies,
guidance documents and decisions related toimmunizations and VPDs;
2. Increase LHD participation in national policy andprogrammatic discussions;
3. Collect, organize and disseminate
recommendations, evidence-based strategies, tools
and resources through NACCHO communication
channels;
4. Evaluate model practices to assess accessibility,utility, and impact of materials disseminated;
5. Identify pockets of low vaccination withincommunities;
6. Promote a pro-vaccination campaign to containvaccine misinformation;
7. Provide on-going support to local healthdepartments;

NACCHO Immunization Program Activities

Local Public Health Initiatives to Increase
Vaccine Confidence

Equipping Local Health Departments toAddress Vaccine Hesitancy

NACCHO COVID-19 Response Efforts
NACCHO Response Level 2:• Maintain situational awareness, at both the national/federal andlocal level;• Support all stakeholders through the constant sharing ofinformation to help protect the public;• Facilitate the sharing of information from the federal to the locallevel;• Advocate for federal funding for the COVID-19 response andpublic health infrastructure for the future;• Understand and be responsive to member needs and requests;• And convey the critical role of local health departments duringongoing outbreaks.

NACCHO COVID-19 Response Efforts• DATA/GIS Special Task Force• COVID-19 Virtual Community• Contact Tracing Resources for
COVID-19 Response• Local Health Department
Stories from the Field

NACCHO COVID-19
Vaccine Response Efforts• Impact of COVID-19 Response on Local Health Department
Immunization Programs• High Level Notes for Jurisdiction Operations/Local Plan Collection• Policy Statements and Letters• Story from the Field: Innovative Ways to Maintain Immunization
Coverage During a Pandemic• Immunization webinar series• Immunization in a Time of COVID-19• COVID-19: Vaccination Planning and Local Health Departments• COVID-19 Vaccination Program Interim Playbook and Planning for Local
Health Departments• Vaccine Administration Planning: Drive-thru Clinics and Other InnovativeIdeas• The Impact of COVID-19 on School Re-opening• Technology Approaches to Managing COVID-19 Vaccine• Engaging Communities to Increase Confidence in COVID-19 Vaccines• Pfizer-BioNTech COVID-19 Training and Education• Understanding Diverse Communities to Support Equitable and Informed
COVID-19 Vaccine Decision Making

Role of NACCHO members invaccination program• October 2020 States submitted COVID-19vaccination plans• State plans varied in how they integrated
local health departments• December 2020 Two vaccines areapproved for FDA EUA and ACIP
recommended• ACIP recommendations provide guidanceon priority groups 1 a, 1b, 1c• January 2021 Local health departmentsthat are engaged in vaccine delivery havestarted to share COVID-19 Vaccination
Plans

Realities of Vaccination Efforts

Low Supply; HighDemandVariance inVaccination
Distribution byState

Changing GuidanceComplexities ofVaccine Storageand Handling

Vaccine Hesitancy

Two Dose Series

Equitable
Allocation***Working with Local Public Health toAddress COVID-19
Understand Local HealthDepartments• National Profile of Local Health
Departments

https://www.naccho.org/resources/lhdresearch/national-profile-of-local-healthdepartments• 2018 Preparedness Profile Assessment
https://www.naccho.org/blog/articles/thelandscape-of-local-public-health-preparednessfindings-from-the-2018-preparedness-profileassessment

Working with Local Public Health toAddress COVID-19
Reach out to Local Public Health• Regional Healthcare Coalitions

https://www.naccho.org/blog/articles/healthcarecoalitions-as-response-entities• NACCHO Directory of Local HealthDepartments
https://www.naccho.org/membership/lhddirectory• State Associations of County and City
Health Officials (SACCHOs)

https://www.naccho.org/membership/meet-ourmembers/saccho
Source: National Association of County and City Health Officials (NACCHO) 2018 Preparedness Profile Assessment

Working with Local Public Health toAddress COVID-19
Work with NACCHO• NACCHO Funding Opportunities

https://www.naccho.org/opportunities/opportunit
ies/funding-opportunities• NACCHO Consulting• General and COVID-19 related inquiries
may be submitted to NACCHO throughPreparedness@naccho.org

Thank You!

Questions
For Dr. Routh (CDC) and Dr. Alleyne (NACCHO)On the topic of transportation and COVID-19vaccination efforts

39

ABOUT CTAA (COMMUNITY TRANSPORTATIONASSN. OF AMERICA)
A National Membership Association comprised of:• Rural Public Transit• Small-Urban Transit• Non-Emergency Medical Transportation (NEMT)• Specialized Transit (older adults & people with disabilities)• Tribal Transit• Volunteer Transit• Veterans Transit• State DOTs/State Transit Associations

CTAA’S MOBILITY VISION• Community-based• Flexible• Responsive• Accessible• Multi-modal/Mobility Management

Audience Polling Questions

42Our Panelists
Panel moderated by Scott Bogren

Bryan
Baker

EricGleason

Dr. Sarah
McAdooClary Mole,Jr.

Dan
Wedge

Transportation
Director,
SPARTAN
Transportation
Services
Levelland,
Texas

Director of
PublicTransportation
at the Texas
State
Department ofTransportation

Population
HealthCapstone
Director, U. of
Mass Medical
School –Baystate;
Member of theSpringfield, MA
VaccinationForce

EMS Specialistat the Office ofEmergency
MedicalServices at theNational
Highway
Traffic Safety
Administration

Executive
Director ofService forAlleganCounty andresponsible forAlleganCountyTransportation

43

As we close . . .
§ Please share your examples of collaboration:
nc4mm.org/covid-19-resource-center/44

Seek NCMM’s assistance in connecting with yourlocal public health/public transportation agency

Find your NCMM regional liaison:
https://nationalcenterformobilitymanagement.org/aboutus/who-we-are/As we close . . .
§ Planning a follow-up webinar in 6-8 weeks to share collaborations
among public health, public transportation, and emergency
services§ This webinar is being recorded. The recording, slides, and atranscript will be posted at nc4mm.org/covid-19-resource-center/46

THANK YOU